Investing.com - Financial Markets Worldwide

Gulf Pharm Ind (JULPHAR)

Abu Dhabi
Currency in AED
1.450
+0.020(+1.40%)
Closed·

JULPHAR Financial Summary

Key Ratios

P/E Ratio72.08
Price/Book1.68
Debt / Equity62.05%
Return on Equity2.61%
Dividend Yield0.00%
EBITDA167.20M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa5731,143.21,616.11,277.51,312.5
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa185.1383.4557.9425.1519.1
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa-20841.5-28.6-24.575
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa-293.264.4-29.4-99.144.6
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa2,327.32,426.32,399.42,453.92,441
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa973.4645.9598.5699.1925.8
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa1,069.9963.8928.2806.2809.6
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-72.05-226.98-64.742.8-286.4
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa-168.246.219.393.6245
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-13.9-39.8-7.3-24.2-118.6
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa189.170.1-26.378-190.3
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa14.969.3-56.6124.4-94.5
* In Millions of AED (except for per share items)

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 1.560
(+7.59% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
0.02 / --
Revenue / Forecast
359.20M / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Gulf Pharm Ind's earnings for the latest quarter?

The Gulf Pharm Ind EPS (TTM) is 0.02. Gulf Pharm Ind reported sales of 359.20, net income of 140.90, and EPS of 0.02 for the latest quarter.

What was Gulf Pharm Ind's net income for the latest quarter?

Gulf Pharm Ind's net income for the latest quarter was 140.90.

How did Gulf Pharm Ind's performance compare year-over-year in the latest quarter?

The company's revenue moved from 12.30 in the previous quarter to 359.20 in the latest quarter, and net income moved from 51.90 to 140.90 compared to the previous quarter.

What is Gulf Pharm Ind's net profit margin on a TTM basis?

Gulf Pharm Ind's trailing twelve months (TTM) net profit margin is 3.40%.

How does Gulf Pharm Ind's debt to equity ratio compare to industry standards?

Gulf Pharm Ind's total debt-to-equity ratio is 62.05%.

What is Gulf Pharm Ind's return on investment on a TTM basis?

Gulf Pharm Ind's trailing twelve months (TTM) return on investment (ROI) is 2.61%.

Did Gulf Pharm Ind gain or lose cash last quarter?

In the latest quarter, Gulf Pharm Ind's net change in cash was 336.70 million.

What were Gulf Pharm Ind's total assets and liabilities in the latest quarter?

As of the latest quarter, Gulf Pharm Ind reported total assets of 2,031.40 million and total liabilities of 529.10 million.

How has Gulf Pharm Ind's total revenue grown this year?

Gulf Pharm Ind's total revenue was 12.30 in the previous quarter and 359.20 in the latest quarter.

What is Gulf Pharm Ind's gross margin on a TTM basis?

Gulf Pharm Ind's trailing twelve months (TTM) gross margin is 40.56%.

What was Gulf Pharm Ind's revenue per share for the latest quarter?

Gulf Pharm Ind's revenue per share for the latest quarter was 1.16.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.